Literature DB >> 6367496

Open trial of S-adenosylmethionine for treatment of depression.

J F Lipinski, B M Cohen, F Frankenburg, M Tohen, C Waternaux, R Altesman, B Jones, P Harris.   

Abstract

Nine depressed inpatients completed trials with S-adenosylmethionine. Seven showed improvement or remission of their symptoms. As in European studies, no side effects were seen except the apparent induction of mania in two patients with bipolar disorder.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6367496     DOI： 10.1176/ajp.141.3.448

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  16 in total

1.  A Case Report of a Manic Episode Triggered by S-Adenosylmethionine (SAMe).

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-08

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

3.  Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats.

Authors:  A Benelli; M Filaferro; A Bertolini; S Genedani
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 4.  S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.

Authors:  Anup Sharma; Patricia Gerbarg; Teodoro Bottiglieri; Lila Massoumi; Linda L Carpenter; Helen Lavretsky; Philip R Muskin; Richard P Brown; David Mischoulon
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

5.  Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders.

Authors:  Helen Lavretsky
Journal:  Aging health       Date:  2009-02-01

Review 6.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

8.  Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers.

Authors:  P Giulidori; M Cortellaro; G Moreo; G Stramentinoli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Michael A Thompson; Brent A Bauer; Laura L Loehrer; Stephen S Cha; Jayawant N Mandrekar; Amit Sood; Dietlind L Wahner-Roedler
Journal:  J Altern Complement Med       Date:  2009-05       Impact factor: 2.579

Review 10.  S-adenosyl-methionine in depression: a comprehensive review of the literature.

Authors:  George I Papakostas; Jonathan E Alpert; Maurizio Fava
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.